Roka Bioscience (ROKA) Misses Q1 EPS by 1c

Roka Bioscience (NASDAQ: ROKA) reported Q1 EPS of ($0.51), $0.01 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $1.44 million.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Arena Group to rename as Paradium.AI, ticker changing to PAAI